Start Your Search
EP1.01 - Advanced NSCLC (ID 150)
- Event: WCLC 2019
- Type: E-Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
- Presentations: 1
- Now Available
- Coordinates: 9/08/2019, 08:00 - 18:00, Exhibit Hall
EP1.01-34 - A Retrospective Study of the Pattern of Lymph Node Metastasis in Superior Sulcus Non-Small-Cell Lung Cancers (Now Available) (ID 1742)
08:00 - 18:00 | Presenting Author(s): Hongxuan Li
By comparing the probability of lymph node metastasis between superior sulcus non–small-cell lung cancers (SS NSCLC) and non-SS NSCLC located in the pulmonary apex, we hope to find out whether there is a unique pattern of lymph node metastasis in SS NSCLC.Method
During 2008-2014, a retrospective study was performed on NSCLC patients with lesions located in the pulmonary apex. Patients with lesions invading the peripheral tissue structure were enrolled in the SS NSCLC group, while those without lesions invading the peripheral structure were enrolled in the non-SS NSCLC group. A total of 65 patients in the SS NSCLC group received surgery, and all patients in the non-SS NSCLC group received surgery. According to postoperative pathology and enhanced CT before treatment, the location and number of lymph node metastasis were determined. The chi-square test was used to statistically analyze the difference in the probability of N1, N2 and distant metastasis (DM) between the two groups.Result
Compared with the non-SS NSCLC group, the T staging of SS NSCLC group was advanced, but the rate of N1 lymph node metastasis was similar. However, the N2 lymph node metastasis rate of the SS NSCLC was significantly lower than that of the non-SS NSCLC, which was 25.3% and 39.8% respectively (P=0.048). Distant metastasis rates were similar at lower levels in both groups，which was 9.3% and 6.4% respectively (P=0.471).
Table Basic information and results SS NSCLC N0n-SS NSCLC P value Chi-square Gender male 67 65 female 8 28 Median age 61(37-87) 62（42-82） ad 27 67 Pathology squ 32 16 others 16 10 T stage T3+T4 75(100%) 3(3.2%) 0.000* 156.328 N1 25(33.3%) 33(35.8%) 0.771 0.085 N2 19(25.3%) 37(39.8%) 0.048* 3.902 DM 7(9.3%) 6(6.4%) 0.471 0.519
Ad：adenocarcinoma squ: squamous carcinoma DM：distant metastasis
* P<0.05. There were significant differences between the two groups.
Although T staging was very late in SS NSCLC, the N2 lymph node metastasis rate and distant metastasis rate did not increase correspondingly. Therefore, enhanced local treatment, such as neoadjuvant concurrent chemoradiotherapy combined with surgery, may lead to better survival benefits.
Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.